Connection

Merryn Voysey to Pneumococcal Vaccines

This is a "connection" page, showing publications Merryn Voysey has written about Pneumococcal Vaccines.
Connection Strength

1.502
  1. Serotype-Specific Correlates of Protection for Pneumococcal Carriage: An Analysis of Immunity in 19 Countries. Clin Infect Dis. 2018 03 05; 66(6):913-920.
    View in: PubMed
    Score: 0.467
  2. Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates. Vaccine. 2017 10 13; 35(43):5850-5857.
    View in: PubMed
    Score: 0.453
  3. Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial. Lancet Infect Dis. 2019 02; 19(2):156-164.
    View in: PubMed
    Score: 0.124
  4. Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias. PLoS One. 2018; 13(9):e0202517.
    View in: PubMed
    Score: 0.121
  5. Differences in Immunization Site Pain in Toddlers Vaccinated With Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2018 04; 37(4):e103-e106.
    View in: PubMed
    Score: 0.117
  6. Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule. Pediatr Infect Dis J. 2017 May; 36(5):e130-e135.
    View in: PubMed
    Score: 0.110
  7. Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13. Vaccine. 2017 05 09; 35(20):2701-2708.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.